Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

    Get Diamond plan for FREE

    logo

    Trillium Therapeutics Inc. (TRIL)

    Price:

    18.44 USD

    ( - 0 USD)

    Your position:

    0 USD

    ACTION PANEL
    CREATE A NOTE
    ABOUT
    Symbol
    TRIL
    Name
    Trillium Therapeutics Inc.
    Industry
    Biotechnology
    Sector
    Healthcare
    Price
    18.440
    Market Cap
    0
    Enterprise value
    985.225M
    Currency
    USD
    Ceo
    Jan Skvarka
    Full Time Employees
    33
    Ipo Date
    2005-01-11
    City
    Mississauga
    Address
    2488 Dunwin Dr

    Check the

    KEY TAKEAWAYS

    ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
    Descriptive alt text

    (REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION

    SIMILAR COMPANIES STI SCORE

    Similar STI Score

    Regeneron Pharmaceuticals, Inc.

    VALUE SCORE:

    6

    Symbol
    REGN
    Market Cap
    61.406B
    Industry
    Biotechnology
    Sector
    Healthcare

    2nd position

    Genmab A/S

    VALUE SCORE:

    11

    Symbol
    GMAB
    Market Cap
    99.056B
    Industry
    Biotechnology
    Sector
    Healthcare

    The best

    Agios Pharmaceuticals, Inc.

    VALUE SCORE:

    12

    Symbol
    AGIO
    Market Cap
    2.254B
    Industry
    Biotechnology
    Sector
    Healthcare
    FUNDAMENTALS
    P/E
    -26.023
    P/S
    0
    P/B
    5.538
    Debt/Equity
    0.003
    EV/FCF
    10.855
    Price to operating cash flow
    -1.000
    Price to free cash flow
    -1.000
    EV/sales
    -1.667k
    Earnings yield
    -0.038
    Debt/assets
    0.003
    FUNDAMENTALS
    Net debt/ebidta
    4.207
    Interest coverage
    0
    Research And Developement To Revenue
    171.270
    Intangile to total assets
    0
    Capex to operating cash flow
    0
    Capex to revenue
    0
    Capex to depreciation
    0
    Return on tangible assets
    -0.197
    Debt to market cap
    Piotroski Score
    FUNDAMENTALS
    PEG
    -0.260
    P/CF
    -67.936
    P/FCF
    0
    RoA %
    -19.728
    RoIC %
    -22.011
    Gross Profit Margin %
    0.100
    Quick Ratio
    13.938
    Current Ratio
    13.938
    Net Profit Margin %
    -40.099k
    Net-Net
    3.223
    FUNDAMENTALS PER SHARE
    FCF per share
    -0.271
    Revenue per share
    0.002
    Net income per share
    -0.709
    Operating cash flow per share
    -0.271
    Free cash flow per share
    -0.271
    Cash per share
    3.477
    Book value per share
    3.329
    Tangible book value per share
    3.329
    Shareholders equity per share
    3.329
    Interest debt per share
    0.010
    TECHNICAL
    52 weeks high
    20.960
    52 weeks low
    5.800
    Current trading session High
    18.490
    Current trading session Low
    17.830
    DIVIDEND
    Dividend yield
    0.00%
    Payout ratio
    0.00%
    Years of div. Increase
    0
    Years of div.
    0
    Q-shift
    Dividend per share
    0
    SIMILAR COMPANIES
    DESCRIPTION

    Trillium Therapeutics Inc., a clinical stage immuno-oncology company, develops therapies for the treatment of cancer. The company's lead program is TTI-621, a SIRPaFc fusion protein that acts a soluble decoy receptor preventing CD47 from delivering its inhibitory signal, which is in Phase I clinical trial for advanced relapsed or refractory hematologic malignancies, and solid tumors and mycosis fungoides. Its product candidates also include TTI-622 that is in Phase I clinical trial of immunoglobulin G4 SIRPaFc protein; and TTI-10001, a small molecule stimulator of interferon genes agonist that senses cytosolic DNA for promoting tumor immunity, which is in the discovery Phase. The company was formerly known as Stem Cell Therapeutics Corp. and changed its name to Trillium Therapeutics Inc. in June 2014. Trillium Therapeutics Inc. was founded in 2004 is headquartered in Mississauga, Canada.

    NEWS
    https://images.financialmodelingprep.com/news/london-capital-markets-have-been-surprisingly-active-in-2023-20230803.jpg
    London capital markets have been surprisingly active in 2023, right?

    proactiveinvestors.co.uk

    2023-08-03 09:22:48

    Is it as grim as it seems for the City of London right now? Perhaps not, according to the London Stock Exchange's recent capital markets update for the first half of 2023.

    https://images.financialmodelingprep.com/news/mda-breakout-stocksetfs-week-12-march-2023-highfrequency-gainers-20230319.jpg
    MDA Breakout Stocks/ETFs Week 12 - March 2023: High-Frequency Gainers To Give You An Edge

    seekingalpha.com

    2023-03-19 07:43:18

    Two new Breakout Stocks for Week 12 with better than 10% short-term upside with ETFs and a Dow 30 Pick. Average cumulative returns for 2023 are +37.3% YTD. The Momentum Gauges® continue negative in bear funds from Mar 7th led by BNKD +65.7%. EGO peaked at +8.3% gains for members.

    https://images.financialmodelingprep.com/news/week-27-mda-breakout-stocks-july-2022-shortterm-picks-to-20220705.jpg
    Week 27 MDA Breakout Stocks - July 2022: Short-Term Picks To Give You An Edge

    seekingalpha.com

    2022-07-05 10:57:47

    Two new Breakout Stocks for Week 27 with better than 10% short-term upside potential and a Dow 30 Pick. Average cumulative returns now down to +85.6% YTD.

    https://images.financialmodelingprep.com/news/week-15-mda-breakout-stocks-april-2022-shortterm-picks-to-20220410.jpg
    Week 15 MDA Breakout Stocks - April 2022: Short-Term Picks To Give You An Edge

    seekingalpha.com

    2022-04-10 06:12:48

    Week 15 MDA Breakout Stocks - April 2022: Short-Term Picks To Give You An Edge

    https://images.financialmodelingprep.com/news/week-13-mda-breakout-stocks-april-2022-shortterm-picks-20220328.jpg
    Week 13 MDA Breakout Stocks - April 2022: Short-Term Picks To Give You An Edge

    seekingalpha.com

    2022-03-28 06:13:56

    Two sample Breakout Stocks for Week 13 with better than 10% short-term upside potential and a Dow stock pick.

    https://images.financialmodelingprep.com/news/week-11-mda-breakout-stocks-march-2022-shortterm-picks-20220313.jpg
    Week 11 MDA Breakout Stocks - March 2022: Short-Term Picks To Give You An Edge

    seekingalpha.com

    2022-03-13 04:42:09

    Week 11 MDA Breakout Stocks - March 2022: Short-Term Picks To Give You An Edge

    https://images.financialmodelingprep.com/news/week-10-mda-breakout-stocks-march-2022-shortterm-picks-20220306.jpg
    Week 10 MDA Breakout Stocks - March 2022: Short-Term Picks To Give You An Edge

    seekingalpha.com

    2022-03-06 08:26:41

    Week 10 MDA Breakout Stocks - March 2022: Short-Term Picks To Give You An Edge

    https://images.financialmodelingprep.com/news/week-9-mda-breakout-stocks-march-2022-shortterm-picks-20220227.jpg
    Week 9 MDA Breakout Stocks - March 2022: Short-Term Picks To Give You An Edge

    seekingalpha.com

    2022-02-27 07:06:11

    Week 9 MDA Breakout Stocks - March 2022: Short-Term Picks To Give You An Edge

    https://images.financialmodelingprep.com/news/week-8-mda-breakout-stocks-february-2022-shortterm-picks-20220220.jpg
    Week 8 MDA Breakout Stocks - February 2022: Short-Term Picks To Give You An Edge

    seekingalpha.com

    2022-02-20 06:17:07

    Two sample Breakout Stocks for Week 8 with better than 10% short-term upside potential and a Dow stock pick. The negative Momentum Gauge® signal continues into 2022 without a buy signal for the MDA breakout picks in one of the worst starts to the stock market since 2008.

    https://images.financialmodelingprep.com/news/week-7-mda-breakout-stocks-february-2022-shortterm-picks-20220213.jpg
    Week 7 MDA Breakout Stocks - February 2022: Short-Term Picks To Give You An Edge

    seekingalpha.com

    2022-02-13 07:36:26

    Week 7 MDA Breakout Stocks - February 2022: Short-Term Picks To Give You An Edge

    https://images.financialmodelingprep.com/news/week-5-mda-breakout-stocks-february-2022-shortterm-picks-20220130.jpg
    Week 5 MDA Breakout Stocks - February 2022: Short-Term Picks To Give You An Edge

    seekingalpha.com

    2022-01-30 07:22:21

    Week 5 MDA Breakout Stocks - February 2022: Short-Term Picks To Give You An Edge

    https://images.financialmodelingprep.com/news/week-4-mda-breakout-stocks-january-2022-shortterm-picks-20220124.jpg
    Week 4 MDA Breakout Stocks - January 2022: Short-Term Picks To Give You An Edge

    seekingalpha.com

    2022-01-24 12:36:36

    Week 4 MDA Breakout Stocks - January 2022: Short-Term Picks To Give You An Edge

    https://images.financialmodelingprep.com/news/week-3-mda-breakout-stocks-january-2022-shortterm-picks-20220115.jpg
    Week 3 MDA Breakout Stocks - January 2022: Short-Term Picks To Give You An Edge

    seekingalpha.com

    2022-01-15 10:01:46

    Two sample Breakout Stocks for Week 3 with better than 10% short-term upside potential and a Dow stock pick. This past week was a negative momentum signal and no picks beat 10% peak gains with the picks down -0.08% in total led by TDW +4% and HXL +2.1%.

    https://images.financialmodelingprep.com/news/week-2-mda-breakout-stocks-january-2022-shortterm-picks-20220109.jpg
    Week 2 MDA Breakout Stocks - January 2022: Short-Term Picks To Give You An Edge

    seekingalpha.com

    2022-01-09 09:20:49

    Two sample Breakout Stocks for Week 2 with better than 10% short-term upside potential and a Dow stock pick. This past week, 3 stocks beat 10% peak gains with RES +29.2%, UGRO +11.0%, and DYAI +10.2% with Momentum Gauge® values still high negative.

    https://images.financialmodelingprep.com/news/week-1-mda-breakout-stocks-january-2022-shortterm-picks-to-20220102.jpg
    Week 1 MDA Breakout Stocks - January 2022: Short-Term Picks To Give You An Edge

    seekingalpha.com

    2022-01-02 12:35:44

    Two sample Breakout Stocks for Week 1 with better than 10% short-term upside potential and a Dow stock pick. This past week 1 stock beat 10% peak gains with AEHR +27.2% and METC +8.6% with Momentum Gauge® values still negative.

    https://images.financialmodelingprep.com/news/week-52-mda-breakout-stocks-december-2021-shortterm-picks-20211224.jpeg
    Week 52 MDA Breakout Stocks - December 2021: Short-Term Picks To Give You An Edge

    seekingalpha.com

    2021-12-24 13:51:31

    Two sample Breakout Stocks for Week 52 with better than 10% short-term upside potential and a Dow stock pick. This past week, two stocks beat 10% peak gains in FLGT +19.1% and DYAI +13.8% with Momentum Gauge® values improving through the week.